Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence

Almost forty years ago, it was first hypothesized that an increased dietary intake of omega-3 polyunsaturated fatty acids (PUFA) from fish fat could exert protective effects against several pathologies. Decades of intense preclinical investigation have supported this hypothesis in a variety of model...

Full description

Bibliographic Details
Main Authors: Weylandt, Karsten H., Serini, Simona, Chen, Yong Q., Su, Hui-Min, Lim, Kyu, Cittadini, Achille, Calviello, Gabriella
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537707/
id pubmed-4537707
recordtype oai_dc
spelling pubmed-45377072015-08-23 Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence Weylandt, Karsten H. Serini, Simona Chen, Yong Q. Su, Hui-Min Lim, Kyu Cittadini, Achille Calviello, Gabriella Review Article Almost forty years ago, it was first hypothesized that an increased dietary intake of omega-3 polyunsaturated fatty acids (PUFA) from fish fat could exert protective effects against several pathologies. Decades of intense preclinical investigation have supported this hypothesis in a variety of model systems. Several clinical cardiovascular studies demonstrated the beneficial health effects of omega-3 PUFA, leading medical institutions worldwide to publish recommendations for their increased intake. However, particularly in recent years, contradictory results have been obtained in human studies focusing on cardiovascular disease and the clinical evidence in other diseases, particularly chronic inflammatory and neoplastic diseases, was never established to a degree that led to clear approval of treatment with omega-3 PUFA. Recent data not in line with the previous findings have sparked a debate on the health efficacy of omega-3 PUFA and the usefulness of increasing their intake for the prevention of a number of pathologies. In this review, we aim to examine the controversies on the possible use of these fatty acids as preventive/curative tools against the development of cardiovascular, metabolic, and inflammatory diseases, as well as several kinds of cancer. Hindawi Publishing Corporation 2015 2015-08-02 /pmc/articles/PMC4537707/ /pubmed/26301240 http://dx.doi.org/10.1155/2015/143109 Text en Copyright © 2015 Karsten H. Weylandt et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Weylandt, Karsten H.
Serini, Simona
Chen, Yong Q.
Su, Hui-Min
Lim, Kyu
Cittadini, Achille
Calviello, Gabriella
spellingShingle Weylandt, Karsten H.
Serini, Simona
Chen, Yong Q.
Su, Hui-Min
Lim, Kyu
Cittadini, Achille
Calviello, Gabriella
Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence
author_facet Weylandt, Karsten H.
Serini, Simona
Chen, Yong Q.
Su, Hui-Min
Lim, Kyu
Cittadini, Achille
Calviello, Gabriella
author_sort Weylandt, Karsten H.
title Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence
title_short Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence
title_full Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence
title_fullStr Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence
title_full_unstemmed Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence
title_sort omega-3 polyunsaturated fatty acids: the way forward in times of mixed evidence
description Almost forty years ago, it was first hypothesized that an increased dietary intake of omega-3 polyunsaturated fatty acids (PUFA) from fish fat could exert protective effects against several pathologies. Decades of intense preclinical investigation have supported this hypothesis in a variety of model systems. Several clinical cardiovascular studies demonstrated the beneficial health effects of omega-3 PUFA, leading medical institutions worldwide to publish recommendations for their increased intake. However, particularly in recent years, contradictory results have been obtained in human studies focusing on cardiovascular disease and the clinical evidence in other diseases, particularly chronic inflammatory and neoplastic diseases, was never established to a degree that led to clear approval of treatment with omega-3 PUFA. Recent data not in line with the previous findings have sparked a debate on the health efficacy of omega-3 PUFA and the usefulness of increasing their intake for the prevention of a number of pathologies. In this review, we aim to examine the controversies on the possible use of these fatty acids as preventive/curative tools against the development of cardiovascular, metabolic, and inflammatory diseases, as well as several kinds of cancer.
publisher Hindawi Publishing Corporation
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537707/
_version_ 1613260127335350272